Novo Nordisk A/S Sponsored ADR Class B

NVOSTOCK

Hold

Score+0.409

About

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Sector: Health Technology
Industry: Pharmaceuticals: Major
Founded: 1923
IPO: 1974-05-17

novonordisk.com

On this page

Rebuzz Analysis

Hold

Last updated Apr 1, 2026, 8:20 PM UTC

Rebuzz Score

+0.409

Buy zone

SSSHBSB

-1.0-0.40.00.41.0

Score Breakdown

Market Price

Loading market data...

Signal History

Community

Total Mentions

High Authority

CommunityMentionsScoreSignal

r/wallstreetbetsMed

10.500

Bullish

About Novo Nordisk A/S Sponsored ADR Class B

Scroll here to load company intelligence.

News

Scroll here to load latest news and sentiment.